title: Treatment of myoclonus.
abstract: Myoclonus creates significant disability for patients. This symptom or sign can have many different etiologies, presentations, and pathophysiological mechanisms. A thorough evaluation for the myoclonus etiology is critical for developing a treatment strategy. The best etiological classification scheme is a modified version from that proposed by Marsden et al. in 1982. Clinical neurophysiology, as assessed by electromyography and electroencephalography, can be used to classify the pathophysiology of the myoclonus using a neurophysiology classification scheme. If the etiology of the myoclonus cannot be reversed or treated, then symptomatic treatment of the myoclonus itself may be warranted. Unfortunately, there are few controlled studies for myoclonus treatments. The treatment strategy for the myoclonus is best derived from the neurophysiology classification scheme categories: 1) cortical, 2) cortical-subcortical, 3) subcortical-nonsegmental, 4) segmental, and 5) peripheral. A cortical physiology classification is most common. Levetiracetam is suggested as first-line treatment for cortical myoclonus, but valproic acid and clonazepam are commonly used. Cortical-subcortical myoclonus is the physiology demonstrated by myoclonic seizures, such as in primary epileptic myoclonus (e.g., juvenile myoclonic epilepsy). Valproic acid has demonstrated efficacy in such epileptic syndromes with other medications providing an adjunctive role. Clonazepam is used for subcortical-nonsegmental myoclonus, but other treatments, depending on the syndrome, have been used for this physiological type of myoclonus. Segmental myoclonus is difficult to treat, but clonazepam and botulinum toxin are used. Botulinum toxin is used for focal examples of peripheral myoclonus. Myoclonus treatment is commonly not effective and/or limited by side effects.
authors.affiliation: Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Blvd., Scottsdale, AZ, 85259, USA, jcaviness@mayo.edu.
authors.forename: John N
authors.initials: JN
authors.lastname: Caviness
mesh_terms: D000927:Anticonvulsants / Q000627:therapeutic use*; D006801:Humans; D009207:Myoclonus / Q000145:classification / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000927:Anticonvulsants
references.citation: Lancet Neurol. 2010 Oct;9(10):1028-36
references.pmid: 20864054
references.citation: Epileptic Disord. 2000 Dec;2(4):209-12
references.pmid: 11174151
references.citation: J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):457-8
references.pmid: 12235322
references.citation: Epilepsy Res. 1998 Jan;29(2):147-54
references.pmid: 9477147
references.citation: Arch Neurol. 1986 Oct;43(10):1025-31
references.pmid: 3753263
references.citation: J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):797-804
references.pmid: 8021664
references.citation: J Clin Neurosci. 2010 Aug;17(8):959-65
references.pmid: 20493708
references.citation: J Neurol. 1988 Mar;235(4):214-8
references.pmid: 3373239
references.citation: Epilepsia. 2016 Feb;57(2):210-21
references.pmid: 26666500
references.citation: Epilepsia. 2003;44 Suppl 2:7-15
references.pmid: 12752456
references.citation: Mov Disord. 1996 Nov;11(6):748-51
references.pmid: 8914109
references.citation: Eur Neurol. 2002;48(1):52-3
references.pmid: 12138315
references.citation: Mov Disord. 1995 Jan;10(1):22-7
references.pmid: 7885352
references.citation: Medicine (Baltimore). 1988 Mar;67(2):100-9
references.pmid: 3352511
references.citation: Mov Disord. 1993;8(1):63-8
references.pmid: 8419809
references.citation: Epilepsia. 2005;46 Suppl 9:34-47
references.pmid: 16302874
references.citation: Adv Neurol. 2005;95:289-98
references.pmid: 15508932
references.citation: Epilepsia. 1982 Dec;23(6):693-720
references.pmid: 6816580
references.citation: J Med Assoc Thai. 2002 Mar;85(3):392-5
references.pmid: 12117033
references.citation: Muscle Nerve. 2000 Mar;23(3):321-35
references.pmid: 10679708
references.citation: Epilepsy Res. 1998 Jan;29(2):109-14
references.pmid: 9477142
references.citation: Suppl Clin Neurophysiol. 2004;57:425-32
references.pmid: 16106642
references.citation: Adv Neurol. 1986;43:687-706
references.pmid: 2868623
references.citation: J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):344-8
references.pmid: 9527146
references.citation: Clin Neurosci. 1995-1996;3(4):253-7
references.pmid: 8891399
references.citation: Otol Neurotol. 2003 Sep;24(5):714-6
references.pmid: 14501444
references.citation: J Spinal Cord Med. 2006;29(4):413-24
references.pmid: 17044393
references.citation: Paraplegia. 1995 Nov;33(11):678-81
references.pmid: 8584305
references.citation: Epilepsia. 1986 May-Jun;27(3):177-82
references.pmid: 3084227
references.citation: Arch Neurol. 1986 Nov;43(11):1165-75
references.pmid: 3535750
references.citation: Adv Neurol. 2005;95:307-23
references.pmid: 15508934
references.citation: Neurol India. 2004 Dec;52(4):520-1
references.pmid: 15626860
references.citation: Arq Neuropsiquiatr. 2000 Sep;58(3B):901-4
references.pmid: 11018829
references.citation: Lancet Neurol. 2004 Oct;3(10):598-607
references.pmid: 15380156
references.citation: Ann Neurol. 1995 Feb;37(2):146-57
references.pmid: 7847856
references.citation: Neurology. 2008 Dec 9;71(24):1981-5
references.pmid: 19064879
references.citation: Neurology. 2005 Sep 13;65(5):762-4
references.pmid: 16157917
references.citation: Neurology. 1999 Jan 1;52(1):211-3
references.pmid: 9921884
references.citation: Neurology. 2001 Sep 25;57(6):1112-4
references.pmid: 11571347
references.citation: Seizure. 1996 Jun;5(2):149-51
references.pmid: 8795132
references.citation: Mov Disord. 1998 Nov;13(6):971-2
references.pmid: 9827626
references.citation: Mov Disord. 2013 Mar;28(3):282-7
references.pmid: 23401150
references.citation: Curr Opin Neurol. 2005 Apr;18(2):147-53
references.pmid: 15791145
references.citation: Epilepsia. 2003;44 Suppl 11:27-37
references.pmid: 14641568
references.citation: Neurology. 2008 Mar 25;70(13):1010-6
references.pmid: 18362280
references.citation: J Neurol. 2006 Jul;253(7):857-60
references.pmid: 16845571
references.citation: Mov Disord. 1997 May;12(3):438-42
references.pmid: 9159744
references.citation: Brain. 1977 Sep;100(3):455-87
references.pmid: 412560
references.citation: Seizure. 2002 Mar;11(2):136-7
references.pmid: 11945102
references.citation: Mov Disord. 2009 Mar 15;24(4):479-89
references.pmid: 19117361
references.citation: Clin Neurophysiol. 2004 Jan;115(1):50-8
references.pmid: 14706468
references.citation: J Neurol Sci. 2012 Feb 15;313(1-2):32-4
references.pmid: 22014609
references.citation: Neurology. 2005 Dec 27;65(12):1967-9
references.pmid: 16382538
references.citation: No To Shinkei. 1986 Apr;38(4):359-62
references.pmid: 3718780
references.citation: Neurology. 2000 Mar 14;54(5):1201
references.pmid: 10720302
references.citation: Brain. 1989 Jun;112 ( Pt 3):765-77
references.pmid: 2499399
references.citation: J Neural Transm (Vienna). 2007;114(12):1547-51
references.pmid: 17690949
references.citation: Adv Neurol. 1986;43:629-43
references.pmid: 2418652
references.citation: Seizure. 2001 Sep;10(6):424-7
references.pmid: 11700996
references.citation: Otol Neurotol. 2006 Aug;27(5):672-5
references.pmid: 16868515
references.citation: Neurology. 2007 Jan 30;68(5):E4
references.pmid: 17261675
references.citation: Parkinsonism Relat Disord. 2013 Aug;19(8):758-60
references.pmid: 23632325
references.citation: Curr Opin Neurol. 1997 Apr;10(2):115-20
references.pmid: 9147002
references.citation: Neurology. 2009 Apr 14;72(15):1301-9
references.pmid: 19365051
references.citation: Mov Disord. 1999 Jan;14(1):182-5
references.pmid: 9918374
references.citation: J Neurol. 2010 Aug;257(8):1349-55
references.pmid: 20352254
references.citation: Mayo Clin Proc. 1999 Jun;74(6):565-9
references.pmid: 10377930
references.citation: Adv Neurol. 1986;43:645-51
references.pmid: 2418653
references.citation: Arch Neurol. 2001 May;58(5):781-6
references.pmid: 11346373
references.citation: Mov Disord. 1996 Nov;11(6):691-700
references.pmid: 8914096
references.citation: Muscle Nerve. 2007 Jul;36(1):14-20
references.pmid: 17410591
references.citation: J Neurol Neurosurg Psychiatry. 1979 Jan;42(1):52-5
references.pmid: 762584
references.citation: Curr Opin Neurol. 2012 Aug;25(4):507-12
references.pmid: 22610460